|
AMGN
|
Amgen Inc.
|
8.14%
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
7.41%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
7.21%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
6.12%
|
US
|
NASDAQ
|
|
ILMN
|
Illumina, Inc.
|
5.67%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13%
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
2.25%
|
US
|
NASDAQ
|
|
INCY
|
Incyte Corporation
|
2.09%
|
US
|
NASDAQ
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
1.91%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
1.60%
|
US
|
NASDAQ
|
|
SNY
|
Sanofi
|
1.29%
|
US
|
NASDAQ
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
1.16%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
1.15%
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
1.10%
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
1.03%
|
US
|
NASDAQ
|
|
TECH
|
Techne Corporation
|
1.02%
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
1.02%
|
US
|
NASDAQ
|
|
GH
|
Guardant Health, Inc.
|
0.96%
|
US
|
NASDAQ
|
|
HZNP
|
Horizon Pharma, Inc.
|
0.87%
|
US
|
NASDAQ
|
|
AMRN
|
Amarin Corporation plc
|
0.85%
|
US
|
NASDAQ
|